Combination Therapy of PPARγ Ligands and Inhibitors of Arachidonic Acid in Lung Cancer

Tan, Y. H. C. (2010). Interplay between anticancer drugs and their effector proteins on therapeutics of lung cancer [doctoral dissertation, National Taiwan Normal University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0021-1610201315185360
Wang, T. C. (2022). The role of α-Linolenic Acid in Inhibition of Lung Cancer Metastasis [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU202203272
Shimizu, M., & Moriwaki, H. (2008). Synergistic Effects of PPARγ Ligands and Retinoids in Cancer Treatment. PPAR Research, 2008(), 181-190-016. https://doi.org/10.1155/2008/181047
Hazra, S., Peebles, K. A., Sharma, S., Mao, J. T., & Dubinett, S. M. (2008). The Role of PPARγ in the Cyclooxygenase Pathway in Lung Cancer. PPAR Research, 2008(), 82-88-108. https://doi.org/10.1155/2008/790568
Hatton, J. L., & Yee, L. D. (2008). Clinical Use of PPARγ Ligands in Cancer. PPAR Research, 2008(), 110-122-009. https://doi.org/10.1155/2008/159415